| |
| |
|
| Insider
Information: |
Haumann Brett K |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
242,499 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,058,817 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
242,499 |
|
|
| Total
Value |
$2,058,817 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 1.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Theravance Biopharma, Inc. |
TBPH |
Chief Medical Officer |
2021-02-20 |
242,499 |
2015-02-05 |
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2018-11-20 |
4 |
D |
$24.79 |
$182,653 |
D/D |
(7,368) |
134,911 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
247,161 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-02-20 |
4 |
D |
$27.00 |
$210,006 |
D/D |
(7,778) |
239,383 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-05-20 |
4 |
D |
$19.84 |
$53,667 |
D/D |
(2,705) |
236,678 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-08-20 |
4 |
D |
$21.51 |
$58,292 |
D/D |
(2,710) |
233,968 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-11-20 |
4 |
D |
$17.60 |
$47,379 |
D/D |
(2,692) |
231,276 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
350,276 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$870,447 |
D/D |
(33,608) |
316,668 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2020-05-20 |
4 |
D |
$26.67 |
$112,334 |
D/D |
(4,212) |
312,456 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Clinical Development |
• – – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
140,714 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Clinical Development |
• – – |
2015-11-20 |
4 |
D |
$17.17 |
$13,410 |
D/D |
(781) |
139,933 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Clinical Development |
• – – |
2016-02-20 |
4 |
D |
$15.65 |
$288,351 |
D/D |
(18,425) |
121,508 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
